Category: Cancer Treatment

Clay Siegall; Revolutionizing The Battle Against Cancer


Clay Siegall is the mastermind behind the establishment of Seattle Genetics, a leading pharmaceutical firm that targets the cure of chronic illnesses. Clay has in his possession a degree in Zoology from the University of Maryland as well as a doctorate in Genetics from the George Washington University.

 

Since the commencement of Seattle Genetics, the company has made revolutionary accomplishments in the targeted remedy industry. The firm recently became the pioneering institution to develop an antibody drug conjugate accredited by the Food and Drug Administration. This invention, along with other that are currently in the works, has earned Seattle Genetics productive partnerships with industry giants such as Pfizer and Bayer.

 

Furthermore, Seattle Genetics has undergone massive growth, transforming from a novice to a renowned entity. Despite this remarkable achievements, Clay visualizes an even bigger future, with the company becoming a global figure. Siegall also believes that current oncologic procedures such as chemotherapies have their days numbered, as the industry embraces the up and coming targeted therapies which are far more efficient and bearable.

 

Clay developed an interest in medicine and technology from a tender age. The passion for developing cancer therapy came to him while he was an undergraduate. A close relative of his was a cancer patient, who had chemotherapy administered on him. The effects of the medication were adverse and almost deadly, so Clay embarked on a mission to find a more sustainable alternative. The motivation to have autonomy as well as make money also drove Clay to inaugurate Seattle Genetics.

 

Seattle Genetics makes money in many ways, among which the primary means is through direct sales of products and services. Also, the company gets a significant proportion of profits from leasing out technologies they pioneered. The company had a tough stat, but everything started to run smoothly after conducting the IPO. At a given period, the company almost went on its knees, as the capital was almost depleted.

 

The company employs sales staff that are well acquainted with pharmaceutical products and terminologies. For this reason, they have maintained a respectable number of customers in their client base. The institution also ensures that there is a close rapport between them and their clientele.

 

 

Cancer Treatment Center of America (CTCA) Unveils a Leading-edge Clinical Pathways, a Customized Platform for Cancer Treatment


Cancer Treatment Centers of America has entered an innovative partnership with Allscripts and NantHealth, which will see the three partners execute a custom technical solution. This technical support solution allows eviti, a cutting-edge NantHealth clinical solution, to acquire information on clinical workflows on the electronic health record of Allscripts Sunrise. The Clinical Pathways program offers information about the cancer treatment procedure, without necessarily interfering with the doctor’s clinical workflow. Hundreds of oncologists based in the U.S. participated in the designing of the clinical operating system’s interface. The system harbors an all-inclusive collection of growing cancer care data.

As stated in the article, “Cancer Treatment Centers of America® Partners with Allscripts and NantHealth to Launch Clinical Pathways, a Comprehensive and Custom Oncology Treatment Platform,” Clinical Pathways avails all correct treatment alternatives. CMO of CTCA, George Daneker, said that the Clinical Pathways assists in the elimination of possible guesswork by physicians. The program incorporates new cancer research, treatment procedures, and alternative therapies into electronic health record (EHR) Allscripts Sunrise.

Benefits of the treatment platform

• Personalized treatment procedures that address the individual needs of patients, their health, as well as definite disease state

• Supported clinical data

Easy access to reliable information on adverse drug rates, response rates, and toxicity

• Instantaneous functionality

What is Cancer Treatment Centers of America?

The Florida-based Cancer Treatment Centers of America (CTCA) is a renowned national, for-profit partnership of five hospitals, which serve cancer patients across the U.S. CTCA approaches cancer treatment in an integrative manner that entails utilization of conventional techniques, such as chemotherapy, immunotherapy, radiation, and surgery, to manage cancer. Additionally, these hospitals provide integrative therapies to minimize side effects, including nausea, malnutrition, anxiety, lymphedema, fatigue, depression, and depression.

After cancer had claimed the life of his mother, Mr. Richard J Stephenson became more focused on finding an effective treatment for the life-threatening disease. He oversaw the launch of the first CTCA hospital back in 1988. Four other health care centers opened their doors from 2005 to 2012.

Supportive Therapies and Treatment Options Set The Cancer Treatment Centers of America Apart From Other Hospitals


Cancer Treatment Centers of America (CTCA) recently announced their adoption of the Clinical Pathways program, a NantHealth technology-based clinical decision support platform that will effectively organize all of the new cancer treatment information available to oncologists. Curated by oncologists, oncology associations, government agencies and more, the program offers information on more than 2,700 treatment options for all types of cancers.

According to Wikipedia, while the Clinical Pathways program makes it easy for oncologists to discuss options with their patients and to order a chemotherapy regimen, the program empowers patients as well. CTCA’s patients are able to view the same information as their oncologist about their available options, including response rates, clinical data, toxicity and more.

Based in Boca Raton, Florida, https://www.myctca.com/ operates five non-profit hospitals nationwide; in addition, they maintain a presence in the Caribbean, Latin America and the Middle East for individuals interested in visiting one of CTCA’s U.S. locations. CTCA is famous for their integrative approach to cancer treatments, which comprises of chemotherapy and radiation therapy, plus supportive therapies that combat stress, depression, pain and other effects of cancer treatments. Few cancer treatment centers offer the supportive therapies that the CTCA hospitals do, which include acupuncture, mind-body medicine, nutrition therapy and more.

At CTCA, all of the medical professionals specialize in patient-centered cancer care; patients select the latest technologies and therapies available to them after learning about all of their options from the Clinical Pathways program. Patients also enjoy coordinated care where all of their health care providers are located at one hospital.

For further information about CTCA follow them on Facebook.